VACBF
Nykode Therapeutics AS

6
Mkt Cap
$124.09M
Volume
4,367.00
52W High
$0.38
52W Low
$0.1558
PE Ratio
-11.28
VACBF Fundamentals
Price
$0.38
Prev Close
$0.31
Open
$0.38
50D MA
$0.2391
Beta
0.00
Avg. Volume
503.50
EPS (Annual)
-$0.1189
P/B
1.25
Rev/Employee
$62,438.85
$24.38
Loading...
Loading...

About

Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. It focuses on developing field of individualized cancer neoantigen vaccines by using the Vaccibody technology to generate therapeutics to treat cancer. The company was founded by Inger Sandlie and Agnete Brunsvik Fredriksen on November 22, 2006 and is headquartered in Oslo, Norway.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
139

Frequently Asked Questions

What is Market Cap of Nykode Therapeutics AS?
What is the 52-week high for Nykode Therapeutics AS?
What is the 52-week low for Nykode Therapeutics AS?
What is Nykode Therapeutics AS stock price today?
What was Nykode Therapeutics AS stock price yesterday?
What is the PE ratio of Nykode Therapeutics AS?
What is the Price-to-Book ratio of Nykode Therapeutics AS?
What is the 50-day moving average of Nykode Therapeutics AS?
How many employees does Nykode Therapeutics AS have?

Latest VACBF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.